Position in CGC
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$3,633
New position
Shares Held
3,829
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Western Wealth Management, LLC holds $1,402,818 across 21 Drug Manufacturers - Specialty & Generic names. CGC ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XERS |
Xeris Biopharma Holdings, Inc.
|
75,675 | $438,915 | |
| 2 | ZTS |
Zoetis Inc.
|
2,714 | $320,821 | |
| 3 | LQDA |
Liquidia Corp
|
7,373 | $278,257 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
7,992 | $165,913 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,441 | $43,402 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,025 | $31,242 | |
| 7 | HLN |
Haleon plc
|
2,872 | $28,748 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
335 | $25,409 |
All Filings in CGC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,633 | 3,829 | Shares | Sole | 2026-05-19 | |
| No filing history on record for this holder in this stock. | ||||||